IA
ABUS icon

IFP Advisors’s Arbutus Biopharma ABUS Stock Holding History

IFP Advisors’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Hold
0
– – – 3132
2025
Q1 		– Hold
0
– – – 3672
2024
Q4 		– Hold
0
– – – 3780
2019
Q1 		– Sell
-10
Closed – – 2346
2018
Q4 		$0 Hold
10
– – ﹤0.01% 3492
2018
Q3 		$0 Hold
10
– – ﹤0.01% 3796
2018
Q2 		$0 Hold
10
– – ﹤0.01% 3850
2018
Q1 		$0 Hold
10
– – ﹤0.01% 3733
2017
Q4 		$0 Sell
10
-350
-97% -$2.05K ﹤0.01% 3783
2017
Q3 		$2K Hold
360
– – ﹤0.01% 3712
2017
Q2 		$1K Hold
360
– – ﹤0.01% 3844
2017
Q1 		$1K Hold
360
– – ﹤0.01% 3764
2016
Q4 		$1K Buy
360
+350
+3,500% +$1.02K ﹤0.01% 3742
2016
Q3 		$0 Sell
10
-100
-91% -$391 ﹤0.01% 3879
2016
Q2 		$0 Buy
+110
New +$466 ﹤0.01% 3808
2016
Q1 		– Sell
-110
Closed – – 2342
2015
Q4 		$0 Buy
+110
New +$603 ﹤0.01% 3701

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
BCP
BlackBarn Capital Partners New York $1.24B AUM 55.98% 1-Year Est. Return